Tadić V, Mijailović Z, Filipović S
Vojnosanit Pregl. 1998 Sep-Oct;55(5):541-50.
To compare and evaluate the data for and against the use of antiarrhythmic agent amiodarone in known cardiological indications.
A MEDLINE search was used to identify the articles dealing with amiodarone, published in the last 15 years.
Articles and studies (uncontrolled retrospective and controlled prospective), as well as case reports speaking decidedly for or against amiodarone were scrutinized.
Simple search, no particular conditions.
Despite very numerous and serious side effects amiodarone is an extraordinary drug and can be recommended for use, provided that the physician is very well acquainted with all implications of its use. Large number of studies on a significant number of patients has proven the efficacy of amiodarone in supraventricular and ventricular arrhythmias of various origin. The drug is particularly suitable for the treatment of ventricular arrhythmia in patients with serious heart failure and impaired function of the left ventricle. It was successfully used in the treatment of malignant ventricular arrhythmias. In patients after myocardial infarction, intravenously administered amiodarone improved the chances of survival as well as the condition of arrhythmia, preventing spreading of the infarction. It is very convenient against ventricular arrhythmia after the successful resuscitation. Short-lasting intravenous administration of amiodarone does not cause serious side effects.
比较和评估支持及反对在已知心脏病适应症中使用抗心律失常药物胺碘酮的数据。
使用MEDLINE检索来识别过去15年发表的有关胺碘酮的文章。
仔细审查了文章和研究(非对照回顾性和对照前瞻性)以及明确支持或反对胺碘酮的病例报告。
简单检索,无特殊条件。
尽管胺碘酮有非常多且严重的副作用,但它是一种非凡的药物,只要医生非常熟悉其使用的所有影响,就可以推荐使用。大量针对大量患者的研究已证明胺碘酮对各种起源的室上性和室性心律失常有效。该药物特别适用于治疗严重心力衰竭和左心室功能受损患者的室性心律失常。它成功用于治疗恶性室性心律失常。在心肌梗死后的患者中,静脉注射胺碘酮可提高生存率并改善心律失常状况,防止梗死扩散。它对于成功复苏后的室性心律失常非常有效。短期静脉注射胺碘酮不会引起严重副作用。